These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

200 related items for PubMed ID: 17229936

  • 1. Chronic treatment with sildenafil improves energy balance and insulin action in high fat-fed conscious mice.
    Ayala JE, Bracy DP, Julien BM, Rottman JN, Fueger PT, Wasserman DH.
    Diabetes; 2007 Apr; 56(4):1025-33. PubMed ID: 17229936
    [Abstract] [Full Text] [Related]

  • 2. Effects of L-arginine and phosphodiesterase-5 inhibitor, sildenafil, on inflammation and airway responsiveness of sensitized BP2 mice.
    Al Qadi-Nassar B, Bichon-Laurent F, Portet K, Tramini P, Arnoux B, Michel A.
    Fundam Clin Pharmacol; 2007 Dec; 21(6):611-20. PubMed ID: 18034662
    [Abstract] [Full Text] [Related]

  • 3. Phosphorylation barriers to skeletal and cardiac muscle glucose uptakes in high-fat fed mice: studies in mice with a 50% reduction of hexokinase II.
    Fueger PT, Lee-Young RS, Shearer J, Bracy DP, Heikkinen S, Laakso M, Rottman JN, Wasserman DH.
    Diabetes; 2007 Oct; 56(10):2476-84. PubMed ID: 17639019
    [Abstract] [Full Text] [Related]

  • 4. Imatinib mesylate improves insulin sensitivity and glucose disposal rates in rats fed a high-fat diet.
    Hägerkvist R, Jansson L, Welsh N.
    Clin Sci (Lond); 2008 Jan; 114(1):65-71. PubMed ID: 17868036
    [Abstract] [Full Text] [Related]

  • 5. Improvement of vascular function by acute and chronic treatment with the PDE-5 inhibitor sildenafil in experimental diabetes mellitus.
    Schäfer A, Fraccarollo D, Pförtsch S, Flierl U, Vogt C, Pfrang J, Kobsar A, Renné T, Eigenthaler M, Ertl G, Bauersachs J.
    Br J Pharmacol; 2008 Mar; 153(5):886-93. PubMed ID: 17891166
    [Abstract] [Full Text] [Related]

  • 6. Hemodynamic effects of combined sildenafil and L-arginine during acute pulmonary embolism-induced pulmonary hypertension.
    Souza-Silva AR, Dias-Junior CA, Uzuelli JA, Moreno H, Evora PR, Tanus-Santos JE.
    Eur J Pharmacol; 2005 Nov 07; 524(1-3):126-31. PubMed ID: 16253237
    [Abstract] [Full Text] [Related]

  • 7. Oxyntomodulin ameliorates glucose intolerance in mice fed a high-fat diet.
    Parlevliet ET, Heijboer AC, Schröder-van der Elst JP, Havekes LM, Romijn JA, Pijl H, Corssmit EP.
    Am J Physiol Endocrinol Metab; 2008 Jan 07; 294(1):E142-7. PubMed ID: 17971509
    [Abstract] [Full Text] [Related]

  • 8. The effect of sildenafil on the altered thoracic aorta smooth muscle responses in rat pre-eclampsia model.
    Turgut NH, Temiz TK, Bagcivan I, Turgut B, Gulturk S, Karadas B.
    Eur J Pharmacol; 2008 Jul 28; 589(1-3):180-7. PubMed ID: 18538317
    [Abstract] [Full Text] [Related]

  • 9. Phosphodiesterase type 5 inhibition reverses impaired forearm exercise-induced vasodilatation in hypertensive patients.
    Attinà TM, Malatino LS, Maxwell SR, Padfield PL, Webb DJ.
    J Hypertens; 2008 Mar 28; 26(3):501-7. PubMed ID: 18300861
    [Abstract] [Full Text] [Related]

  • 10. Chronic PYY3-36 treatment promotes fat oxidation and ameliorates insulin resistance in C57BL6 mice.
    van den Hoek AM, Heijboer AC, Voshol PJ, Havekes LM, Romijn JA, Corssmit EP, Pijl H.
    Am J Physiol Endocrinol Metab; 2007 Jan 28; 292(1):E238-45. PubMed ID: 16940471
    [Abstract] [Full Text] [Related]

  • 11. Four weeks high fat feeding induces insulin resistance without affecting dopamine release or gene expression patterns in the hypothalamus of C57Bl6 mice.
    de Leeuw van Weenen JE, Hu L, Jansen-Van Zelm K, de Vries MG, Tamsma JT, Romijn JA, Pijl H.
    Brain Res; 2009 Jan 23; 1250():141-8. PubMed ID: 19028458
    [Abstract] [Full Text] [Related]

  • 12. Compartmentalization of cardiac beta-adrenergic inotropy modulation by phosphodiesterase type 5.
    Takimoto E, Belardi D, Tocchetti CG, Vahebi S, Cormaci G, Ketner EA, Moens AL, Champion HC, Kass DA.
    Circulation; 2007 Apr 24; 115(16):2159-67. PubMed ID: 17420342
    [Abstract] [Full Text] [Related]

  • 13. Pan-PPAR agonist beneficial effects in overweight mice fed a high-fat high-sucrose diet.
    Fernandes-Santos C, Carneiro RE, de Souza Mendonca L, Aguila MB, Mandarim-de-Lacerda CA.
    Nutrition; 2009 Apr 24; 25(7-8):818-27. PubMed ID: 19268533
    [Abstract] [Full Text] [Related]

  • 14. Transpulmonary B-type natriuretic peptide uptake and cyclic guanosine monophosphate release in heart failure and pulmonary hypertension: the effects of sildenafil.
    Melenovsky V, Al-Hiti H, Kazdova L, Jabor A, Syrovatka P, Malek I, Kettner J, Kautzner J.
    J Am Coll Cardiol; 2009 Aug 11; 54(7):595-600. PubMed ID: 19660688
    [Abstract] [Full Text] [Related]

  • 15. Sildenafil inhibits duodenal contractility via activation of the NO-K+ channel pathway.
    Clemente CM, Araújo PV, Palheta RC, Ratts ZM, Fernandes GH, Rola FH, de Oliveira RB, dos Santos AA, Magalhães PJ.
    Fundam Clin Pharmacol; 2008 Feb 11; 22(1):61-7. PubMed ID: 18251723
    [Abstract] [Full Text] [Related]

  • 16. Essential role of mitochondrial Ca2+-activated and ATP-sensitive K+ channels in sildenafil-induced late cardioprotection.
    Wang X, Fisher PW, Xi L, Kukreja RC.
    J Mol Cell Cardiol; 2008 Jan 11; 44(1):105-13. PubMed ID: 18021798
    [Abstract] [Full Text] [Related]

  • 17. Ranolazine, a novel anti-anginal agent, does not alter isosorbide dinitrate- or sildenafil-induced changes in blood pressure in conscious dogs.
    Zhao G, Messina E, Xu X, Ochoa M, Serpillon S, Shryock J, Belardinelli L, Hintze TH.
    Eur J Pharmacol; 2006 Jul 17; 541(3):171-6. PubMed ID: 16777088
    [Abstract] [Full Text] [Related]

  • 18. Insulin resistance due to chronic salt restriction is corrected by alpha and beta blockade and by L-arginine.
    Ruivo GF, Leandro SM, do Nascimento CA, Catanozi S, Rocha JC, Furukawa LN, Dolnikoff MS, Quintão EC, Heimann JC.
    Physiol Behav; 2006 Jul 30; 88(4-5):364-70. PubMed ID: 16737723
    [Abstract] [Full Text] [Related]

  • 19. Sildenafil (Viagra) evokes retinal arteriolar dilation: dual pathways via NOS activation and phosphodiesterase inhibition.
    Yuan Z, Hein TW, Rosa RH, Kuo L.
    Invest Ophthalmol Vis Sci; 2008 Feb 30; 49(2):720-5. PubMed ID: 18235020
    [Abstract] [Full Text] [Related]

  • 20. Eugenosedin-A prevents hyperglycaemia, hyperlipidaemia and lipid peroxidation in C57BL/6J mice fed a high-fat diet.
    Shen KP, Lin HL, Hsieh SL, Kwan AL, Chen IJ, Wu BN.
    J Pharm Pharmacol; 2009 Apr 30; 61(4):517-25. PubMed ID: 19298700
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.